melanoma

Open Access
Inhibitory Effect of Clopidogrel, a P2Y₁₂ Receptor Antagonist, on Hematogenic Metastasis in B16-BL6 Mouse Melanoma Cells
NORIKO YOSHIKAWA, MINGYU XIA and KAZUKI NAKAMURA

In Vivo May 2025, 39 (3) 1325-1330; DOI: https://doi.org/10.21873/invivo.13936
Open Access
Correlation of Psychosomatic Factors and Personality Traits With the Severity of Melanoma
KONSTANTINOS KONTOANGELOS, VASILIKI NIKOLAOU, AGGELIKI SYRGIANNI, SOFIA TSIORI, CHARALABOS PAPAGEORGIOU and ALEXANDER STRATIGOS

In Vivo November 2024, 38 (6) 2844-2852; DOI: https://doi.org/10.21873/invivo.13765
Open Access
Comparative Analysis of the Effect of the BRAF Inhibitor Dabrafenib in 2D and 3D Cell Culture Models of Human Metastatic Melanoma Cells
DAVID TOVAR-PARRA and MARION ZAMMIT-MANGION

In Vivo July 2024, 38 (4) 1579-1593; DOI: https://doi.org/10.21873/invivo.13608
Open Access
Systemic Scleroderma Induced by Nivolumab in Malignant Melanoma
THIBAUD LOUPRET, ROMAIN BOISSEAU, JEAN-GUILLAUME LOPEZ, PHILIPPE BERTIN and PASCALE VERGNE-SALLE

In Vivo May 2024, 38 (3) 1451-1453; DOI: https://doi.org/10.21873/invivo.13589
Open Access
UVC-Protective Activity of Lemongrass Among 12 Fat-soluble Herbal Extracts: Rapid Decay Due to Cytotoxicity
YUSEI OTAKA, MAKI IZAWA, HIROSHI SAKAGAMI, NORIYOSHI SHIBA, NOBUTOSHI TAKAHASHI, SEI-ICHI TANUMA, SHIGERU AMANO, SHIN UOTA, MEGUMI INOMATA, SATOSHI YOKOSE, KATSUYOSHI SUNAGA, SHINICHIRO HAYASHI, YUKARI KOGA-OGAWA, GIICHIROU NAKAYA and SHINJI KITO

In Vivo November 2023, 37 (6) 2464-2472; DOI: https://doi.org/10.21873/invivo.13353
Open Access
Comprehensive Study of Anti-UVC Activity and Cytotoxicity of Hot-water Soluble Herb Extracts
MAKI IZAWA, YUSEI OTAKA, HIROSHI SAKAGAMI, SEI-ICHI TANUMA, SHIGERU AMANO, SHIN UOTA, MEGUMI INOMATA, YUKA KATO, HIROSHI KADOKURA, SATOSHI YOKOSE, KATSUYOSHI SUNAGA, YUKARI KOGA-OGAWA, GIICHIROU NAKAYA and SHINJI KITO

In Vivo July 2023, 37 (4) 1540-1551; DOI: https://doi.org/10.21873/invivo.13239
Open Access
Cutaneous Melanoma of the Lip: A SEER Analysis of Epidemiology and Survival Outcomes With Focus on Surgery and Other Treatment Options
JUAN A. VISCARDI, MATTEO SCAMPA, SOLANGE N. WALZ, JEROME MARTINEAU, PIETRO G. DI SUMMA, SALVATORE GIORDANO, DANIEL F. KALBERMATTEN and CARLO M. ORANGES

In Vivo May 2023, 37 (3) 1164-1172; DOI: https://doi.org/10.21873/invivo.13191
Open Access
Prominent Anti-UVC Activity of Lignin Degradation Products
HIROSHI SAKAGAMI, SHIGERU AMANO, SHIN UOTA, SEI-ICHI TANUMA, MEGUMI INOMATA, AYAKA SHINDO, MIDORI KUSANO, YUJI KIKKAWA, MISAKI HORIUCHI and TAKAFUMI OOKA

In Vivo November 2022, 36 (6) 2689-2699; DOI: https://doi.org/10.21873/invivo.13004
Open Access
Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells
AYAKA SHINDO, MIDORI KUSANO, HIROSHI SAKAGAMI, SHIGERU AMANO, MEGUMI INOMATA, MASAYO ABE, MASASHI OKAZAWA and TAKAFUMI OOKA

In Vivo September 2022, 36 (5) 2116-2125; DOI: https://doi.org/10.21873/invivo.12937
You have access
3’UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma
DAVID TOVAR-PARRA, SEBASTIÁN RAMIRO GIL-QUIÑONES, JOHN NOVA and LUZ D. GUTIÉRREZ-CASTAÑEDA

In Vivo May 2021, 35 (3) 1529-1536; DOI: https://doi.org/10.21873/invivo.12406

Main menu

User menu

Search

melanoma

Pages